Clinical Trial Update: A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating daratumumab-based therapies in participants with AL amyloidosis; the study is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Amyloidosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING